FDA Approves Therapy to Treat Lung, Pancreatic Cancers
The Food and Drug Administration has approved Merus NV's therapy that targets a particular gene, expanding treatment options for patients with hard-to-treat types of lung and pancreatic cancers, the health regulator said Wednesday.
The Food and Drug Administration has approved Merus NV's therapy that targets a particular gene, expanding treatment options for patients with hard-to-treat types of lung and pancreatic cancers, the health regulator said Wednesday.
What's Your Reaction?
